respiratory condition News
-
BreathSpec differentiates COVID-19 from other infections
Findings of a feasibility study into the potential for breath analysis to help doctors to differentiate between COVID-19 and other respiratory conditions were published in The Lancet on 24 October 2020. The Imspex Group’s BreathSpec instrument showed clusters of breath compounds reflecting the effects of COVID-19’s multi-system nature. Similar clusters were found independently across ...
-
Imspex’s patent portfolio grows
Imspex Diagnostics’ patent portfolio recently grew, with news that the European Patent Office has granted the patent “Method for measuring human exhaled air”. This is the platform that is used to screen for disease indications such as bacterial and viral respiratory tract infections, Group B Streptococcus infection, lung cancer and other chronic inflammatory respiratory ...
-
Nob Hill Therapeutics: Transforming Drug Delivery for Pulmonary Conditions
May 1, 2022 – Inhalation therapies, despite their prevalence in treating pulmonary diseases and respiratory-related conditions, have numerous setbacks, such as the deposition of aerosolized particles in the upper ...
-
Beyond Air Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast
Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that it ...
-
Beyond Air To Participate in Piper’s 34th Annual Healthcare Conference
Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that ...
-
Beyond Air Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast
Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today ...
-
THORASYS receives funding aimed at accelerating innovation
THORASYS is pleased to announce that it is receiving advisory services and up to $197,293 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development project in digital health. Thanks to this support, THORASYS will accelerate a strategic innovation aimed at assessing lung function in remote patient ...
-
Vitalograph celebrates 60th anniversary
Founded in 1963, in Maids Moreton, Vitalograph’s mission has remained unwavering over the past six decades – to improve the lives of people living with lung conditions through the development and manufacture of respiratory diagnostic solutions. As experts in pulmonary function, they also provide clinical drug trial services that enable the development of life-changing respiratory ...
-
BreathSpec and the fight against AMR
The Imspex Group’s BreathSpec technology is well-placed to play a leading role in combatting antimicrobial resistance by helping healthcare practitioners to differentiate between bacterial and viral causes of respiratory infection. This would better allow the right antibiotic to be prescribed to the right patient at the right time and in the right dose , thereby helping to minimise ...
-
Intin, a Digital Healthcare Startup, Honored With the `CES Innovation Award` for Technological Prowess in Healthcare
The COVID-19 pandemic has brought healthcare to the forefront for the global community. Companies and businesses bringing in innovation in healthcare and developing digital healthcare platforms are sought after. Korean company Intin Inc. (https://intin.kr/en/) has been recently honored with the 'Innovation Award' from CES (Consumer Electronics Show) for its 'Oview Multi Device' product, a ...
By INTIN Inc.
-
Acurable launches groundbreaking technology to diagnose sleep apnoea remotely
Acurable, a fast-growing medical device company, has announced the availability of its first product, AcuPebble SA100, a small wearable device which for the first time enables a fully automated and remote diagnosis of obstructive sleep apnoea (OSA). Traditionally, the diagnosis of OSA has required multiple hospital visits for patients, and doctors have had to manually review and analyse data from ...
-
Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions, announced today that the Food and Drug Administration (FDA) has granted it's lead compound, ENA-001, rare pediatric disease designation for the treatment of Apnea of Prematurity. Enalare is planning to develop this unique agnostic ...
-
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Stemedica Cell Technologies, Inc. (“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions. The agreement was ...
-
Beyond Air Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022
Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced ...
-
In a Single Real-World Deployment of over 1,300 Patients, Spire Health’s RPM Service Escalated Patients experiencing Respiratory Exacerbation with 68% Accuracy
Spire Health, the leading provider of remote patient monitoring (RPM) for chronic respiratory disease patients, today announced the results of a real-world study of 1,366 patients at a Virginia-based, multi-provider pulmonary clinic. Among the 188 escalations using Spire’s AI-based system, 68% were pharmacologically treated for acute exacerbation by their pulmonologist. The primary ...
By Spire Health
-
COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities
Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a ...
By MediPines
-
VIDA, UnityPoint Health join forces to modernize lung and respiratory care with agreement to implement AI-powered lung intelligence solutions across the UnityPoint Health system
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has signed an agreement with UnityPoint Health to implement VIDA’s AI-powered lung intelligence and imaging solutions across the UnityPoint Health system. UnityPoint Health is one of the nation’s leading integrated delivery networks, with 21 hospitals and more than ...
-
Asthma Cases Spike in Puerto Rico Following 2017 Hurricane Season
Earlier this year, NBC News published the article, “Puerto Rico faces a spike in asthma cases following Hurricane Maria.” The investigative report specifically looked at the aftermath of the storm that left residents with “mold-producing wreckage across the island and forcing many to use fume-spewing generators for power.” One doctor, interviewed for the piece that treats ...
-
E0467 “Same or Similar” Restrictions Eliminated by Centers for Medicare and Medicaid Services
Bothell, Washington - On May 29, 2020, the Centers for Medicare and Medicaid Services (CMS) updated its policy for HCPCS code E0467 (Multi-Function Ventilator) removing “same or similar” restrictions and paving the way for increased access to integrated respiratory care for ventilator users regardless of their device billing history. Previously, same or similar restrictions ...
-
National Asthma & Allergy Awareness Month and Preventing Occupational Asthma in New York
May is recognized as National Asthma and Allergy Awareness Month across the United States. Asthma is a serious respiratory condition that can be life-threatening in some circumstances. People with the condition are often exposed to numerous known asthma triggers in their homes, schools, and work environments. Occupational asthma, also referred to as work-related asthma, is the most common ...
By VOETS, LLC
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you